Patents On The Technology
ARP’s commitment to developing and protecting the 4JOINTZ® technology is evidenced by its Intellectual Property (IP) portfolio including patents, trademarks, and clinical studies.
The patent specification covers both composition of matter and method of use claims. 4Jointz® utilizes Acteev technology (a combination of a standardized comfrey extract and a pharmaceutical-grade
tannic acid.
Granted Regions
India
Australia
China
Singapore
Russian Federation
New Zealand
Japan
United States
Malaysia
Pending Regions
Thailand
Canada
Hong Kong
European Union